Dosimetric comparison and observation of three-dimensional conformal radiotherapy for recurrent nasopharyngeal carcinoma

Pan,Rongqiang; Wang,Jingming; Qi,Feng; Liu,Ruizhen

doi:10.3892/ol.2017.6732

Dosimetric comparison and observation of three-dimensional conformal radiotherapy for recurrent nasopharyngeal carcinoma

Authors:
- Rongqiang Pan
- Jingming Wang
- Feng Qi
- Ruizhen Liu
View Affiliations

Affiliations: Cancer Center, Nanchong Central Hospital, Nanchong, Sichuan 637000, P.R. China, Department of Ear, Nose and Throat, Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu 730050, P.R. China, Department of Radiotherapy, The First People's Hospital of Shangqiu, Shangqiu, Henan 476100, P.R. China
Published online on: August 8, 2017 https://doi.org/10.3892/ol.2017.6732
Pages: 4741-4745
Copyright: © Pan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the study was to investigate the effect of three-dimensional conformal radiation therapy (3D-CRT) on nasopharyngeal carcinoma (NPC) and the incidence of complications. Between May 2010 and June 2012, 141 patients diagnosed with local recurrence of NPC due to cranial base lesions or cranial nerve symptoms, confirmed by pathology biopsy and/or by CT/MRI, were included in the present study. In accordance with the principle of randomized control, the patients were divided into three groups and treated with three different doses of 3D-CRT. The planned radiotherapy doses of 3D-CRT were 58/1.8-2 Gy, 62/1.8-2 Gy and 68/1.8-2 Gy, respectively. The survival rate, disease-free survival (DFS) rate and local control rate of the three groups of patients were compared as well as the adverse reactions observed after radiotherapy. The prognoses of NPC patients were analyzed by univariate and multivariate analyses. The follow-up rate of the study was 100%. The 5-year overall survival, DFS, and locoregional recurrence-free survival rates were: 43.2 vs. 64.53 vs. 75%, 29.13 vs. 42.82 vs. 39.7% and 30.76 vs. 44.19 vs. 45.4%, respectively. In addition, 62/1.8-2 Gy was similar in treatment effects to 68/1.8-2 Gy, but 68/1.8-2 Gy showed more adverse reactions than 62/1.8-2 Gy. Thus, 62/1.8-2 Gy can be used as a safe and effective dose for 3D-CRT treatment of NPC. Univariate and multivariate analyses showed that age may be the main prognostic factor of patients with NPC. In conclusion, 3D-CRT with a dose of 62/1.8-2 Gy is a safe, effective and tolerable treatment for NPC patients with good clinical value.

View Figures

View References

1	Lv X, Xia WX, Ke LR, Yang J, Qiu WZ, Yu YH, Liang H, Huang XJ, Liu GY, Zeng Q, et al: Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinoma. Onco Targets Ther. 9:5123–5131. 2016. View Article : Google Scholar : PubMed/NCBI
2	Zeng Q, Wang J, Lv X, Li J, Yin LJ, Xiang YQ and Guo X: Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: Finding from a propensity-matched analysis. BMC Cancer. 16:6932016. View Article : Google Scholar : PubMed/NCBI
3	Ho S, Ip W, Chu S, Chan S, Lee B, Chan B, Lee J, Flynn B, Ho W, Sin J, et al: Treatment regret in long-term survivors of nasopharyngeal carcinoma treated with radical radiotherapy. Clin Oncol (R Coll Radiol). 29:e472017. View Article : Google Scholar : PubMed/NCBI
4	Cao C, Luo J, Gao L, Yi J, Huang X, Li S, Xiao J, Zhang Z and Xu G: Magnetic resonance imaging-detected intracranial extension in the T4 classification nasopharyngeal carcinoma with intensity-modulated radiotherapy. Cancer Res Treat. 49:518–525. 2017. View Article : Google Scholar : PubMed/NCBI
5	Lu L, Li J, Zhao C, Xue W, Han F, Tao T, Chang H, Jia W and Lu T: Prognostic efficacy of combining tumor volume with Epstein-Barr virus DNA in patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma. Oral Oncol. 60:18–24. 2016. View Article : Google Scholar : PubMed/NCBI
6	Maingon P, Blanchard P, Bidault F and Calmels L: Radiotherapy for nasopharyngeal carcinoma. Cancer Radiother. 20:S104–S109. 2016.(In French). View Article : Google Scholar : PubMed/NCBI
7	Wang D, Li YH, Fu J and Wang H: Diffusion kurtosis imaging study on temporal lobe after nasopharyngeal carcinoma radiotherapy. Brain Res. 1648:387–393. 2016. View Article : Google Scholar : PubMed/NCBI
8	Nakahara S, Hanamoto A, Seo Y, Miyaguchi S, Yamamoto Y, Tomiyama Y, Yoshii T, Takenaka Y, Yoshioka Y, Isohashi F, et al: Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma, followed by adjuvant chemotherapy for selected patients. Jpn J Clin Oncol. 46:903–910. 2016. View Article : Google Scholar : PubMed/NCBI
9	Ma Q, Wu D, Zeng LL, Shen H, Hu D and Qiu S: Radiation-induced functional connectivity alterations in nasopharyngeal carcinoma patients with radiotherapy. Medicine (Baltimore). 95:e42752016. View Article : Google Scholar : PubMed/NCBI
10	Brown E, Owen R, Harden F, Mengersen K, Oestreich K, Houghton W, Poulsen M, Harris S, Lin C and Porceddu S: Head and neck adaptive radiotherapy: Predicting the time to replan. Asia Pac J Clin Oncol. 12:460–467. 2016. View Article : Google Scholar : PubMed/NCBI
11	Wu SX, Chua DT, Deng ML, Zhao C, Li FY, Sham JS, Wang HY, Bao Y, Gao YH and Zeng ZF: Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 69:761–769. 2007. View Article : Google Scholar : PubMed/NCBI
12	Wong FC, Tung SY, Leung TW, Sze WK, Wong VY, Lui CM and Yuen KK OSK: Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens. Int J Radiat Oncol Biol Phys. 55:1254–1264. 2003. View Article : Google Scholar : PubMed/NCBI
13	Lu J, Cooper J and Lee A: Nasopharyngeal Cancer: Multidisciplinary Management. Springer-Verlag; Berlin, Heidelberg: pp. 253–265. 2010
14	Fee WE Jr, Moir MS, Choi EC and Goffinet D: Nasopharyngectomy for recurrent nasopharyngeal cancer: A 2- to 17-year follow-up. Arch Otolaryngol Head Neck Surg. 128:280–284. 2002. View Article : Google Scholar : PubMed/NCBI
15	Wei W: Cancer of the nasopharynx: Functional surgical salvage. World J Surg. 27:844–848. 2003. View Article : Google Scholar : PubMed/NCBI
16	Law SC, Lam WK, Ng MF, Au SK, Mak WT and Lau WH: Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: An effective means of local salvage. Int J Radiat Oncol Biol Phys. 54:1095–1113. 2002. View Article : Google Scholar : PubMed/NCBI
17	Leung TW, Tung SY, Sze WK, Sze WM, Wong VY and Wong CS OSK: Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 48:1331–1338. 2000. View Article : Google Scholar : PubMed/NCBI
18	Zhang B, Mo Z, Du W, Wang Y, Liu L and Wei Y: Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis. Oral Oncol. 51:1041–1046. 2015. View Article : Google Scholar : PubMed/NCBI
19	Chang JT, See LC, Liao CT, Ng SH, Wang CH, Chen IH, Tsang NM, Tseng CK, Tang SG and Hong JH: Locally recurrent nasopharyngeal carcinoma. Radiother Oncol. 54:135–142. 2000. View Article : Google Scholar : PubMed/NCBI
20	Teo PM, Kwan WH, Chan AT, Lee WY, King WW and Mok CO: How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys. 40:897–913. 1998. View Article : Google Scholar : PubMed/NCBI